The Major Side Effects of Mounjaro, and When They Need Attention

Step 1: What most people notice first, and why it happens

The side effects that arrive earliest are almost always digestive. Nausea tops the list, followed by loose stools, constipation, indigestion, burping and, for some people, vomiting. These reactions are a direct consequence of how tirzepatide works: it slows gastric emptying, so food sits in the stomach longer than usual. Your system takes time to adapt. The NHS patient information for tirzepatide lists these among the most common effects, and the clinical trial data behind Mounjaro's licence confirms the same pattern.

For the vast majority of people, the intensity is highest in the first few days after a new dose and then quietens. Eating smaller portions, avoiding fatty or spicy food, and staying well hydrated all help. A question our prescribers hear most weeks is whether nausea means the treatment isn't right for them, in most cases it doesn't; it means the body is adjusting. That said, if vomiting or diarrhoea is severe enough to prevent normal fluid intake, that tips into territory worth contacting a clinician about. Dehydration can affect kidney function, and that is a risk worth taking seriously.

Other early effects some people report include headache, fatigue and dizziness, particularly in the first pen, and anyone who wants a fuller picture of what to expect can read through our guide to Mounjaro side effects, which covers each reaction in detail. Injection-site reactions (mild redness or itching at the site) are also common and almost always short-lived. Rotating between the abdomen, thigh and upper arm from one week to the next reduces localised irritation.

Step 2: Less common but more serious, recognising the signs that need urgent help

A smaller group of people experience side effects that go beyond inconvenience. The one that clinicians are most alert to is acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines, explicitly calling out pancreatitis as an infrequent but potentially serious reaction associated with tirzepatide and its class. The hallmark symptom is severe, persistent stomach pain that radiates towards the back, which may or may not be accompanied by vomiting. If that describes what you are feeling, stop taking Mounjaro and go to A&E or call 999. Do not wait to see whether it settles.

Gallbladder problems (gallstones and inflammation of the gallbladder) are also recorded in Mounjaro's safety data. Rapid weight loss itself is a known gallstone risk factor, so clinicians keep an eye on this. Upper-right abdominal pain, fever and yellowing of the skin or eyes are signs to act on without delay.

Serious allergic reactions are rare but possible. Swelling of the face, lips, throat or tongue, difficulty breathing, or a widespread rash after injection are all reasons to call 999 immediately. For people with a history of certain thyroid conditions (medullary thyroid carcinoma or MEN2 syndrome), Mounjaro is contraindicated, this is something a prescriber checks before treatment starts, not something that surfaces as a surprise.

Those who want a broader picture of how individual symptoms present can read our detail on the side effects of Mounjaro page, which covers each one in more depth.

Step 3: Side effects that can catch people off guard, longer-term considerations

Beyond the early weeks, a few effects are worth knowing about in advance so they do not come as a surprise. Muscle loss is a documented concern with any significant calorie reduction: Mounjaro reduces appetite substantially, and without deliberate attention to protein intake and resistance activity, lean mass can fall alongside fat. This is not unique to Mounjaro, but the speed of weight loss the medicine can produce makes it worth planning for from the start.

For women taking the oral contraceptive pill, tirzepatide's effect on gastric emptying may reduce pill absorption, particularly in the first four weeks of treatment and for four weeks after each dose increase. NHS guidance recommends adding a non-oral contraceptive method (such as condoms) during those windows. For women on HRT, NHS England advises discussing transdermal forms (patches or gels) with your doctor for the same reason.

Low mood, anxiety and (very rarely) thoughts of self-harm have been reported with GLP-1 medicines, and our page covering the 5 Mounjaro side effects that most commonly catch people off guard includes a closer look at how these mood-related reactions present. This is not common, but it is in the safety monitoring data, and it deserves to be taken seriously rather than attributed to something else. Anyone who wants to understand what the research says about cardiovascular risk during tirzepatide treatment can find a detailed analysis on our cardiovascular risk meta-analysis page.

When to get medical help, a plain summary

Contact a GP or call 111 if you have: nausea or vomiting that stops you eating or drinking normally; prolonged or severe diarrhoea; signs of a gallbladder problem (right-sided abdominal pain with fever); sudden unexplained changes in vision; or significant mood changes. Go to A&E or call 999 for: severe persistent abdominal pain that reaches the back (possible pancreatitis); signs of a serious allergic reaction (facial or throat swelling, difficulty breathing); or chest pain.

The Yellow Card scheme means you don't have to rely solely on your prescriber to flag a concern. The MHRA wants to hear directly from patients when a medicine may have caused a reaction, it is how post-market safety signals get identified. You can also report a suspected counterfeit or unlicensed seller via the same route, which matters given the risks around buying Mounjaro from unverified sources.

Mounjaro is a Black Triangle medicine, meaning it carries additional monitoring requirements precisely because it is newer and the full long-term picture is still being built. That is normal for medicines at this stage of their licensing, it is not a reason for alarm, but it is a reason to keep communicating with your clinical team throughout treatment.

Our prescribers discuss individual risk profiles, current medications and realistic expectations as part of every consultation. If you are weighing up whether tirzepatide is the right fit for your circumstances, exploring the treatment options available through nume is a useful starting point. For general questions about what the programme involves, our FAQs cover the process in plain terms.